20105 results for «»
20105 results
Handling STEMI complications: From rescue PCI to recalcitrant calcified nodules
05 Oct 2024 – From AICT-AsiaPCR 2024
Explore this captivating session showcasing a diverse array of complex STEMI cases from the AICT-AsiaPCR 2024 conference. Dive into riveting narratives that go beyond the basics, including a primary PCI rescue mission, managing an anomalous left main coronary artery, navigating ACS with intracardiac thrombi, and tackling...
Bifurcation and stable CAD: Tackling challenges in complex clinical scenarios
05 Oct 2024 – From AICT-AsiaPCR 2024
Immerse yourself in this session featuring a selection of complex bifurcation and stable coronary artery disease cases from the AICT-AsiaPCR 2024 conference. Witness the navigation of challenging scenarios, including the use of a coronary sinus reducer, managing a hidden coronary artery ostium, and cracking calcified conundrums...
TAVI and Mitral: Advanced techniques for complex valve interventions
05 Oct 2024 – From AICT-AsiaPCR 2024
Delve into this captivating session showcasing a diverse range of TAVI and mitral valve interventions from the AICT-AsiaPCR 2024 conference. Witness the navigation of complex cases, including a mitral valve-in-ring procedure, a percutaneous mitral commissurotomy in a pregnant patient, and the management of unexpected complications during...
AICT-AsiaPCR 2024 Opening ceremony
04 Oct 2024 – From AICT-AsiaPCR 2024
In the AICT-AsiaPCR 2024 opening ceremony, discover the key figures, explore the programme, and learn about the national societies and working groups involved. Highlights include the Chien Foundation Lifetime Achievement Award in cardiovascular intervention, the nomination of the APSIC Fellows 2024, and insights into Asia Intervention...
AICT-AsiaPCR 2024 Awards ceremony
05 Oct 2024 – From AICT-AsiaPCR 2024
Join us for this exciting awards ceremony, where you'll first meet the three winners selected from 322 candidates across 27 countries who received accolades for the best clinical cases. Witness the presentation of the award-winning case titled 'Percutaneous Intervention of Stuck Prosthetic Mitral Valve'. Following that,...
AICT-AsiaPCR 2024 Closing ceremony
05 Oct 2024 – From AICT-AsiaPCR 2024
As the 2024 edition of AICT-AsiaPCR comes to a close, this special ceremony offers a moment to thank everyone who contributed to its success. It’s a chance to reflect on the highlights and achievements of the event, supported by memorable images, while also offering a preview...
Latest advances in interventional cardiology: Top abstracts on TAVI, PCI, and mitral valve repair
04 Oct 2024 – From AICT-AsiaPCR 2024
Discover the cutting-edge research and innovative solutions presented in the 'Best Abstracts of AICT-AsiaPCR 2024' session. This curated selection showcases the latest advancements in interventional cardiology, from groundbreaking comparisons of transcatheter mitral valve repair techniques to the impact of cerebral embolic protection devices in TAVI procedures....
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
How should I treat a torrential tricuspid valve regurgitation with large coaptation gap size and severe tethered leaflets?
26 Nov 2024
An 84-year-old female patient with severe tricuspid valve regurgitation (TR) and progressive right-sided heart failure signs is referred for diagnosis and treatment. Transoesophageal echocardiography (TEE) reveals isolated torrential TR (5/5) with a large coaptation gap size and tethered leaflets. How would you treat this patient?
Author
Focus on drug coated balloons: evidence and practice
07 Jan 2025
This Special Report led by Andreas Baumbach explores the history, current techniques, evidence, and future of DCBs, plus insights on left main stent restenosis.
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons
23 Jan 2025
Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.
Author
Author
Elana Koss
Manhasset, United States of America
AHA 2024: get the interventional cardiology perspective!
13 Nov 2024
Stay up to date with what is new and hot in interventional cardiology at #AHA24 in Chicago.
SEISMIC-HF I - Exploring non-invasive methods for monitoring intracardiac filling pressures
16 Nov 2024
Luis Ortega provides his take on the SEISMIC-HF I study presented by Liviu Klein at AHA 2024, in Chicago.
Author
The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction
18 Nov 2024
Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.
Author
GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial
21 Nov 2024
Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.
Author
A patient with ISR: what is the role of DCB today?
07 Oct 2024
Watch the replay of this webinar to review the mechanisms of ISR and so much more!
Efficacy and safety of Edoxaban in anticoagulant therapy early after surgical bioprosthetic valve replacement: ENBALV trial
16 Nov 2024
Edoardo Zancanaro provides his take on the ENBALV trial presented by Chisato Izumi at AHA 2024 in Chicago.
Author
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
30 Oct 2024
Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.
Author
Ioannis Lianos
London, United Kingdom